Cardiovascular Systems - Stock Price History | CSII

Historical daily share price chart and data for Cardiovascular Systems since 2020 adjusted for splits. The latest closing stock price for Cardiovascular Systems as of March 27, 2020 is 33.96.
  • The all-time high Cardiovascular Systems stock closing price was 104.00 on August 08, 2006.
  • The Cardiovascular Systems 52-week high stock price is 55.22, which is 62.6% above the current share price.
  • The Cardiovascular Systems 52-week low stock price is 26.00, which is 23.4% below the current share price.
  • The average Cardiovascular Systems stock price for the last 52 weeks is 43.46.
Cardiovascular Systems Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 41.4054 28.3300 52.2000 26.7400 48.5900 70.55%
2018 30.1094 24.2400 39.2500 21.0500 28.4900 20.26%
2017 28.1704 24.1100 32.8900 23.3650 23.6900 -2.15%
2016 18.1133 14.5800 27.1400 7.6700 24.2100 60.12%
2015 26.5858 29.5600 40.9800 13.5400 15.1200 -49.73%
2014 29.6898 33.2400 36.5900 23.6300 30.0800 -12.28%
2013 21.4619 12.9800 34.2900 12.9800 34.2900 173.23%
2012 10.0472 10.1500 12.8900 8.2800 12.5500 27.41%
2011 11.6191 11.7700 16.1000 7.4100 9.8500 -15.52%
2010 5.7042 4.5900 11.7500 3.8500 11.6600 154.03%
2009 7.1025 9.5000 10.3000 3.8400 4.5900 -50.65%
2008 13.9449 30.2000 30.2000 3.5000 9.3000 -70.00%
2007 54.2741 56.5000 70.0000 31.0000 31.0000 -45.99%
2006 83.9558 101.0000 104.0000 51.9000 57.4000 0.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.219B $0.248B
Cardiovascular Systems, Inc., formerly known as Replidyne Inc., is headquartered in Saint Paul, Minnesota. It is a medical device company focusing on developing and commercializing interventional treatment systems for vascular disease. Its initial product, the Diamondback 360? Orbital Atherectomy System, is a minimally invasive catheter system for the treatment of peripheral arterial disease; and a range of plaque types, including calcified vessel lesions. The Diamondback 360? removes soft and calcified plaque in plaque-lined vessels through the orbital rotation of a diamond grit coated offset crown. The company refined its `orbital` technology to address the growing market need of providing a safer more effective atherectomy device.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.686B 23.40
Medtronic (MDT) Ireland $123.215B 16.57
Stryker (SYK) United States $61.179B 19.77
Boston Scientific (BSX) United States $43.868B 19.76
Baxter (BAX) United States $40.667B 24.82
Lonza Group Ag (LZAGY) Switzerland $30.356B 0.00
Coloplast (CLPBY) Denmark $29.419B 45.40
EssilorLuxottica Societe Anonyme (ESLOY) France $26.277B 0.00
Terumo (TRUMY) Japan $23.940B 29.88
ResMed (RMD) United States $21.189B 36.81
Zimmer Biomet Holdings (ZBH) United States $20.816B 12.81
Sunny Optical Technology (SNPTF) China $15.257B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $15.108B 0.00
Insulet (PODD) United States $11.175B 683.73
Bio-Rad Laboratories (BIO) United States $10.212B 47.73
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $6.846B 19.69
DiaSorin S.p.A (DSRLF) Italy $6.714B 0.00
Perrigo (PRGO) Ireland $6.335B 11.55
GN STORE NORD (GNNDY) Denmark $5.510B 28.47
Canopy Growth (CGC) Canada $5.296B 0.00
Haemonetics (HAE) United States $5.273B 32.46
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $3.803B 24.84
Quidel (QDEL) United States $3.726B 32.71
Neogen (NEOG) United States $3.131B 53.04
GW Pharmaceuticals (GWPH) United Kingdom $2.677B 0.00
NuVasive (NUVA) United States $2.614B 20.21
Agios Pharmaceuticals (AGIO) United States $2.586B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.532B 0.00
Envista Holdings (NVST) United States $2.464B 0.00
National Vision Holdings (EYE) United States $1.777B 29.93
AtriCure (ATRC) United States $1.217B 0.00
TG Therapeutics (TGTX) United States $1.175B 0.00
Aurora Cannabis (ACB) Canada $1.058B 0.00
NanoString Technologies (NSTG) United States $0.993B 0.00
Aphria (APHA) $0.887B 0.00
VAREX IMAGING (VREX) United States $0.814B 16.91
Phibro Animal Health (PAHC) United States $0.810B 16.02
InMode (INMD) Israel $0.779B 0.00
Cerus (CERS) United States $0.707B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.628B 113.00
Omeros (OMER) United States $0.611B 0.00
PetIQ (PETQ) United States $0.605B 16.47
Eagle Pharmaceuticals (EGRX) United States $0.581B 34.52
OraSure Technologies (OSUR) United States $0.502B 62.23
Lantheus Holdings (LNTH) United States $0.501B 11.26
LeMaitre Vascular (LMAT) United States $0.489B 27.52
Surmodics (SRDX) United States $0.465B 53.42
Quanterix (QTRX) United States $0.459B 0.00
Zynex (ZYXI) United States $0.364B 39.64
Owens & Minor (OMI) United States $0.350B 9.57
Vapotherm (VAPO) United States $0.343B 0.00
Organigram Holdings (OGI) Canada $0.338B 0.00
Repro-Med Systems (KRMD) United States $0.318B 200.50
Utah Medical Products (UTMD) United States $0.305B 21.83
Meridian Bioscience (VIVO) United States $0.299B 12.02
MacroGenics (MGNX) United States $0.296B 0.00
HEXO (HEXO) $0.295B 0.00
Exagen (XGN) United States $0.219B 0.00
Cytosorbents (CTSO) United States $0.214B 0.00
Female Health (VERU) United States $0.209B 0.00
BioLife Solutions (BLFS) United States $0.206B 126.00
Rockwell Medical (RMTI) United States $0.169B 0.00
Viemed Healthcare (VMD) United States $0.163B 18.39
InfuSystems Holdings (INFU) United States $0.161B 135.33
Evolus (EOLS) United States $0.152B 0.00
United Health Products (UEEC) United States $0.146B 0.00
Bovie Medical (APYX) United States $0.135B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.118B 0.00
Liberty Health Sciences (LHSIF) Canada $0.113B 0.00
Chimerix (CMRX) United States $0.093B 0.00
Chembio Diagnostics (CEMI) United States $0.092B 0.00
Fonar (FONR) United States $0.091B 6.64
Green Organic Dutchman Holdings (TGODF) Canada $0.078B 0.00
MTech Acquisition (KERN) United States $0.077B 0.00
Brainsway (BWAY) Israel $0.073B 0.00
United-Guardian (UG) United States $0.062B 13.08
Nephros (NEPH) United States $0.057B 0.00
Wound Management Technologies (SMTI) United States $0.054B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.051B 0.00
GUARDION HEALTH (GHSI) United States $0.033B 0.00
ImmuCell (ICCC) United States $0.033B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00
Akers Biosciences Inc (AKER) United States $0.001B 0.00